| Utestående aktier | 33,081,498 shares |
| Insideraktier | 18 917 973 shares |
| Insynsägande | 57,19 % |
| Totalt antal insynspersoner | 18 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
2064 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
NeuroPace, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Accelmed Partners II L.P.
10% Owner -
|
4 432 948 | 4 432 948 | |
| Lisa Andrade | 11 836 | ||
| Joel Becker CHIEF EXECUTIVE OFFICER, Director - [D] [O] | 104 212 | 104 212 | |
| Michael Favet Chief Executive Officer, Director - [D] [O] | 407 080 | 407 080 | |
| Frank M Fischer Director - [D] | 589 531 | 589 531 | |
| Greg Shaw Garfield Director - [D] | 5 614 384 | 5 614 384 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Uri Geiger Director - [D] | 12 036 | 12 036 | |
|
Kck Ltd.
10% Owner -
|
0 | 0 | |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER - [O] | 131 613 | 131 613 | |
| Rakhi Kumar Director - [D] | 15 594 | 15 594 | |
| Joseph Lacob Director - [D] | 12 080 | 12 080 | |
| Martha Morrell CHIEF MEDICAL OFFICER - [O] | 83 480 | 83 480 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Evan Norton Director - [D] | 4 042 657 | 4 042 657 | |
|
Orbimed Advisors Llc
10% Owner -
|
3 238 199 | 3 238 199 | |
|
OrbiMed Capital GP VI LLC
10% Owner -
|
4 012 281 | 3 238 199 | |
| Irina Ridley Chief Legal Officer/Secretary - [O] | 141 139 | 141 139 | |
| Renee Ryan Director - [D] | 41 170 | 41 170 | |
| Williams Patrick F. Chief Financial Officer - [O] | 51 850 | 51 850 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NPCE / NeuroPace, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NPCE / NeuroPace, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-04 | 2025-09-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 9,3600 | −1 337 | −13 | 83 480 | ||||
| 2025-08-28 | 2025-08-27 | 4 | Morrell Martha | NPCE | Common Stock | D | 8,8800 | −357 | −3 | 84 817 | ||||
| 2025-08-28 | 2025-08-27 | 4 | Becker Joel | NPCE | Common Stock | D | 8,8800 | −1 126 | −10 | 104 212 | ||||
| 2025-08-22 | 2025-08-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 8,6600 | −3 052 | −26 | 85 174 | ||||
| 2025-06-24 | 2025-06-20 | 4 | Williams Patrick F. | NPCE | Common Stock | D | 51 850 | 51 850 | ||||||
| 2025-06-24 | 2025-06-21 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 10,4100 | 1 080 | 11 | 12 080 | ||||
| 2025-06-24 | 2025-03-21 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 12,0200 | 935 | 11 | 11 000 | ||||
| 2025-06-24 | 2024-12-21 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 11,5300 | 975 | 11 | 10 065 | ||||
| 2025-06-24 | 2024-09-30 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 6,9700 | 1 614 | 11 | 9 090 | ||||
| 2025-06-24 | 2024-06-28 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 7,5600 | 1 488 | 11 | 7 476 | ||||
| 2025-06-24 | 2024-03-29 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 13,2000 | 852 | 11 | 5 988 | ||||
| 2025-06-24 | 2023-12-29 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 10,3100 | 1 091 | 11 | 5 136 | ||||
| 2025-06-24 | 2023-09-29 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 9,7300 | 1 156 | 11 | 4 045 | ||||
| 2025-06-24 | 2023-06-30 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 4,4900 | 2 505 | 11 | 2 889 | ||||
| 2025-06-24 | 2025-06-21 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 10,4100 | 1 440 | 15 | 15 594 | ||||
| 2025-06-24 | 2025-03-21 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 12,0200 | 1 247 | 15 | 14 154 | ||||
| 2025-06-24 | 2024-12-21 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 11,5300 | 1 300 | 15 | 12 907 | ||||
| 2025-06-24 | 2024-09-30 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 6,9700 | 2 152 | 15 | 11 607 | ||||
| 2025-06-24 | 2024-06-28 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 7,5600 | 1 984 | 15 | 9 455 | ||||
| 2025-06-24 | 2024-03-29 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 13,2000 | 1 136 | 15 | 7 471 | ||||
| 2025-06-24 | 2023-12-29 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 10,3100 | 1 454 | 15 | 6 335 | ||||
| 2025-06-24 | 2023-09-29 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 9,7300 | 1 541 | 15 | 4 881 | ||||
| 2025-06-24 | 2023-06-30 | 4 | Kumar Rakhi | NPCE | Common Stock | D | 4,4900 | 3 340 | 15 | 3 340 | ||||
| 2025-06-24 | 2025-06-21 | 4 | Geiger Uri | NPCE | Common Stock | D | 10,4100 | 1 140 | 12 | 12 036 | ||||
| 2025-06-24 | 2025-03-21 | 4 | Geiger Uri | NPCE | Common Stock | D | 12,0200 | 987 | 12 | 10 896 | ||||
| 2025-06-24 | 2024-12-21 | 4 | Geiger Uri | NPCE | Common Stock | D | 11,5300 | 1 029 | 12 | 9 909 | ||||
| 2025-06-24 | 2024-09-30 | 4 | Geiger Uri | NPCE | Common Stock | D | 6,9700 | 1 703 | 12 | 8 880 | ||||
| 2025-06-24 | 2024-06-28 | 4 | Geiger Uri | NPCE | Common Stock | D | 7,5600 | 1 570 | 12 | 7 177 | ||||
| 2025-06-24 | 2024-03-29 | 4 | Geiger Uri | NPCE | Common Stock | D | 13,2000 | 899 | 12 | 5 607 | ||||
| 2025-06-24 | 2023-12-29 | 4 | Geiger Uri | NPCE | Common Stock | D | 10,3100 | 1 151 | 12 | 4 708 | ||||
| 2025-06-24 | 2023-09-29 | 4 | Geiger Uri | NPCE | Common Stock | D | 9,7300 | 1 220 | 12 | 3 557 | ||||
| 2025-06-24 | 2023-06-30 | 4 | Geiger Uri | NPCE | Common Stock | D | 4,4900 | 2 337 | 10 | 2 337 | ||||
| 2025-06-24 | 2025-06-21 | 4 | Fischer Frank M | NPCE | Common Stock | D | 10,4100 | 2 281 | 24 | 589 531 | ||||
| 2025-06-24 | 2025-03-21 | 4 | Fischer Frank M | NPCE | Common Stock | D | 12,0200 | 1 975 | 24 | 587 250 | ||||
| 2025-06-24 | 2024-12-21 | 4 | Fischer Frank M | NPCE | Common Stock | D | 11,5300 | 2 059 | 24 | 585 275 | ||||
| 2025-06-24 | 2024-09-30 | 4 | Fischer Frank M | NPCE | Common Stock | D | 6,9700 | 3 407 | 24 | 583 216 | ||||
| 2025-06-24 | 2024-06-28 | 4 | Fischer Frank M | NPCE | Common Stock | D | 7,5600 | 3 141 | 24 | 579 809 | ||||
| 2025-06-24 | 2024-03-29 | 4 | Fischer Frank M | NPCE | Common Stock | D | 13,2000 | 1 799 | 24 | 576 668 | ||||
| 2025-06-24 | 2023-12-29 | 4 | Fischer Frank M | NPCE | Common Stock | D | 10,3100 | 2 303 | 24 | 574 869 | ||||
| 2025-06-24 | 2023-09-29 | 4 | Fischer Frank M | NPCE | Common Stock | D | 9,7300 | 2 440 | 24 | 572 566 | ||||
| 2025-06-24 | 2023-06-30 | 4 | Fischer Frank M | NPCE | Common Stock | D | 4,4900 | 4 469 | 20 | 570 126 | ||||
| 2025-06-06 | 2025-06-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 13,5400 | −1 338 | −18 | 85 943 | ||||
| 2025-06-06 | 2025-06-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 13,5400 | −1 337 | −18 | 131 613 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Morrell Martha | NPCE | Common Stock | D | 12,6600 | −357 | −5 | 87 281 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 12,6600 | −357 | −5 | 132 950 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Becker Joel | NPCE | Common Stock | D | 12,6600 | −1 126 | −14 | 105 338 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 17,9900 | −3 051 | −55 | 87 638 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 17,9900 | −3 051 | −55 | 133 307 | ||||
| 2025-05-16 | 2025-05-14 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 15,9400 | −34 000 | −542 | 3 238 199 | ||||
| 2025-05-16 | 2025-05-14 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 15,8300 | −134 136 | −2 123 | 3 272 199 | ||||
| 2025-04-23 | 2025-04-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 10,9400 | −237 | −3 | 136 358 | ||||
| 2025-04-23 | 2025-04-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 10,9400 | −237 | −3 | 90 689 | ||||
| 2025-03-24 | 2025-03-24 | 4 | Morrell Martha | NPCE | Common Stock | D | 11 700 | 90 926 | ||||||
| 2025-03-20 | 2025-03-10 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 11 700 | 136 595 | ||||||
| 2025-03-20 | 2025-03-10 | 4 | Becker Joel | NPCE | Common Stock | D | 58 500 | 106 464 | ||||||
| 2025-03-20 | 2025-02-27 | 4 | Becker Joel | NPCE | Common Stock | D | 12,5600 | −4 506 | −57 | 47 964 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 11,8100 | −1 337 | −16 | 79 226 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 11,8100 | −1 337 | −16 | 124 895 | ||||
| 2025-03-03 | 2025-02-27 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 12,5600 | −1 430 | −18 | 126 232 | ||||
| 2025-03-03 | 2025-02-27 | 4 | Morrell Martha | NPCE | Common Stock | D | 12,5600 | −1 430 | −18 | 80 563 | ||||
| 2025-02-25 | 2025-02-21 | 4 | Morrell Martha | NPCE | Common Stock | D | 13,7213 | −78 334 | −1 075 | 81 993 | ||||
| 2025-02-25 | 2024-02-12 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 50 000 | 1 | 160 327 | ||||
| 2025-02-25 | 2025-02-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 14,2300 | −3 405 | −48 | 43 670 | ||||
| 2025-02-25 | 2025-01-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 14,0400 | −265 | −4 | 47 075 | ||||
| 2025-02-25 | 2024-12-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 11,9300 | −1 413 | −17 | 47 340 | ||||
| 2025-02-25 | 2024-11-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 9,1900 | −3 045 | −28 | 48 753 | ||||
| 2025-02-25 | 2024-10-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 6,0000 | −237 | −1 | 51 798 | ||||
| 2025-02-25 | 2024-09-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 7,3900 | −1 334 | −10 | 52 035 | ||||
| 2025-02-25 | 2024-08-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 7,2400 | −3 045 | −22 | 53 369 | ||||
| 2025-02-25 | 2024-07-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 7,6500 | −237 | −2 | 56 414 | ||||
| 2025-02-25 | 2024-06-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 6,4600 | −1 335 | −9 | 56 511 | ||||
| 2025-02-25 | 2024-05-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 7,9800 | −3 045 | −24 | 57 986 | ||||
| 2025-02-25 | 2024-04-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 14,0000 | −237 | −3 | 61 268 | ||||
| 2025-02-25 | 2024-03-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,9900 | −1 334 | −21 | 61 031 | ||||
| 2025-02-25 | 2024-02-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 17,5000 | −12 474 | −218 | 62 602 | ||||
| 2025-02-25 | 2024-01-31 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 40 000 | 1 | 96 480 | ||||
| 2025-02-25 | 2024-01-31 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 12 234 | 0 | 56 480 | ||||
| 2025-02-25 | 2024-01-31 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 192 | 0 | 44 246 | ||||
| 2025-02-25 | 2024-01-31 | 4 | Morrell Martha | NPCE | Common stock | D | 0,0260 | 192 | 0 | 44 246 | ||||
| 2025-02-25 | 2024-01-31 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 192 | 0 | 44 246 | ||||
| 2025-02-25 | 2024-01-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 14,8400 | −264 | −4 | 75 076 | ||||
| 2025-02-25 | 2023-12-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 8,9000 | −1 303 | −12 | 75 340 | ||||
| 2025-02-25 | 2023-10-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 6,8800 | −231 | −2 | 76 643 | ||||
| 2025-02-25 | 2023-09-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 8,9300 | −1 302 | −12 | 76 874 | ||||
| 2025-02-25 | 2023-07-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 4,1300 | −231 | −1 | 78 176 | ||||
| 2025-02-25 | 2023-06-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 4,1100 | −1 303 | −5 | 78 407 | ||||
| 2025-02-25 | 2023-04-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 4,2500 | −231 | −1 | 79 710 | ||||
| 2025-02-25 | 2023-03-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 4,1000 | −5 167 | −21 | 79 941 | ||||
| 2025-02-25 | 2023-01-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 2,9800 | −264 | −1 | 85 108 | ||||
| 2025-02-25 | 2022-10-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 3,0200 | −233 | −1 | 85 372 | ||||
| 2025-02-25 | 2022-07-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 5,5500 | −231 | −1 | 85 605 | ||||
| 2025-02-25 | 2022-04-22 | 4 | Morrell Martha | NPCE | Common Stock | D | 8,3200 | −926 | −8 | 85 836 | ||||
| 2025-02-25 | 2025-02-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 14,2300 | −3 405 | −48 | 127 662 | ||||
| 2025-02-25 | 2025-01-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 14,0400 | −265 | −4 | 118 129 | ||||
| 2025-02-25 | 2024-12-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 11,9300 | −1 334 | −16 | 118 394 | ||||
| 2025-02-25 | 2024-11-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 9,1900 | −3 045 | −28 | 119 728 | ||||
| 2025-02-25 | 2024-10-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 6,0000 | −237 | −1 | 122 773 | ||||
| 2025-02-25 | 2024-09-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 7,3900 | −1 334 | −10 | 123 010 | ||||
| 2025-02-25 | 2024-08-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 7,2400 | −3 045 | −22 | 124 344 | ||||
| 2025-02-25 | 2024-07-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 7,6500 | −237 | −2 | 127 389 | ||||
| 2025-02-25 | 2024-06-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 6,4600 | −1 334 | −9 | 127 626 | ||||
| 2025-02-25 | 2024-05-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 7,9800 | −3 045 | −24 | 128 960 | ||||
| 2025-02-25 | 2024-04-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 14,0000 | −237 | −3 | 132 005 | ||||
| 2025-02-25 | 2024-03-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 15,9900 | −1 042 | −17 | 132 242 | ||||
| 2025-02-25 | 2024-02-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 17,5000 | −9 832 | −172 | 133 284 | ||||
| 2025-02-25 | 2024-01-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 14,8400 | −212 | −3 | 143 116 | ||||
| 2025-02-25 | 2023-12-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 8,9000 | −1 010 | −9 | 143 328 | ||||
| 2025-02-25 | 2023-10-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 6,8800 | −179 | −1 | 144 338 | ||||
| 2025-02-25 | 2023-09-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 8,9300 | −1 010 | −9 | 144 517 | ||||
| 2025-02-25 | 2023-07-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 4,1300 | −179 | −1 | 145 527 | ||||
| 2025-02-25 | 2023-06-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 4,1100 | −1 010 | −4 | 145 706 | ||||
| 2025-02-25 | 2023-04-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 4,2500 | −179 | −1 | 146 716 | ||||
| 2025-02-25 | 2023-03-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 4,1000 | −4 019 | −16 | 146 895 | ||||
| 2025-02-25 | 2023-01-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 2,9800 | −212 | −1 | 150 914 | ||||
| 2025-02-25 | 2022-10-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 3,0200 | −181 | −1 | 151 126 | ||||
| 2025-02-25 | 2022-07-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 5,5500 | −179 | −1 | 151 307 | ||||
| 2025-02-25 | 2022-04-22 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 8,3200 | −718 | −6 | 151 486 | ||||
| 2025-02-20 | 2025-02-20 | 4 | KCK LTD. | NPCE | Common Stock | D | 9,4000 | −5 270 845 | −49 546 | 0 | ||||
| 2025-01-31 | 2025-01-30 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0000 | −200 | −3 | 86 762 | ||||
| 2025-01-31 | 2025-01-29 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0000 | −100 | −2 | 86 962 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0100 | −3 200 | −48 | 87 062 | ||||
| 2024-10-28 | 2024-10-25 | 4 | KCK LTD. | NPCE | Common Stock | D | 5,4513 | −223 991 | −1 221 | 5 270 845 | ||||
| 2024-10-28 | 2024-10-23 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,0200 | −147 | −1 | 5 494 836 | ||||
| 2024-10-24 | 2024-10-22 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,0885 | −4 082 | −25 | 5 494 983 | ||||
| 2024-10-22 | 2024-10-21 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,0964 | −3 720 | −23 | 5 499 065 | ||||
| 2024-10-22 | 2024-10-18 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,2919 | −4 878 | −31 | 5 502 785 | ||||
| 2024-10-18 | 2024-10-17 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,2800 | −3 294 | −21 | 5 507 663 | ||||
| 2024-10-18 | 2024-10-16 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,5705 | −6 900 | −45 | 5 510 957 | ||||
| 2024-10-18 | 2024-10-15 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,4970 | −4 017 | −26 | 5 517 857 | ||||
| 2024-10-18 | 2024-10-14 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,5393 | −4 031 | −26 | 5 521 874 | ||||
| 2024-10-18 | 2024-10-11 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,3451 | −2 572 | −16 | 5 525 905 | ||||
| 2024-10-18 | 2024-10-10 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,1170 | −2 504 | −15 | 5 528 477 | ||||
| 2024-10-18 | 2024-10-09 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,1048 | −3 123 | −19 | 5 530 981 | ||||
| 2024-10-18 | 2024-10-08 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,4253 | −6 000 | −39 | 5 534 104 | ||||
| 2024-10-18 | 2024-10-07 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,6573 | −4 910 | −33 | 5 540 104 | ||||
| 2024-10-18 | 2024-10-04 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,9185 | −5 757 | −40 | 5 545 014 | ||||
| 2024-10-18 | 2024-10-03 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,9665 | −3 318 | −23 | 5 550 771 | ||||
| 2024-10-03 | 2024-10-02 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,8700 | −3 843 | −26 | 5 554 089 | ||||
| 2024-10-03 | 2024-10-01 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,7700 | −4 882 | −33 | 5 557 932 | ||||
| 2024-10-03 | 2024-09-30 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,7300 | −4 749 | −32 | 5 562 814 | ||||
| 2024-10-03 | 2024-09-27 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,6300 | −5 059 | −34 | 5 567 563 | ||||
| 2024-10-03 | 2024-09-26 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,6200 | −5 821 | −39 | 5 572 622 | ||||
| 2024-10-03 | 2024-09-25 | 4 | KCK LTD. | NPCE | Common Stock | D | 6,6000 | −5 858 | −39 | 5 578 443 | ||||
| 2024-10-03 | 2024-09-23 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,5400 | −282 | −2 | 5 584 301 | ||||
| 2024-10-03 | 2024-09-20 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,5000 | −765 | −6 | 5 584 583 | ||||
| 2024-10-03 | 2024-09-13 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,5900 | −1 993 | −15 | 5 585 348 | ||||
| 2024-10-03 | 2024-09-06 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,5000 | −11 | −0 | 5 587 341 | ||||
| 2024-10-03 | 2024-09-04 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,5000 | −14 | −0 | 5 587 352 | ||||
| 2024-10-03 | 2024-09-03 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,6000 | −2 093 | −16 | 5 587 366 | ||||
| 2024-10-03 | 2024-08-30 | 4 | KCK LTD. | NPCE | Common Stock | D | 7,7600 | −4 314 | −33 | 5 589 459 | ||||
| 2024-05-03 | 2024-05-03 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0300 | −4 674 | −66 | 3 406 335 | ||||
| 2024-05-03 | 2024-05-02 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0100 | −8 842 | −124 | 3 411 009 | ||||
| 2024-05-03 | 2024-05-01 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0200 | −15 690 | −220 | 3 419 851 | ||||
| 2024-04-26 | 2024-04-24 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0600 | −1 781 | −25 | 3 435 541 | ||||
| 2024-04-23 | 2024-04-23 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,2900 | −21 791 | −311 | 3 437 322 | ||||
| 2024-04-23 | 2024-04-22 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0500 | −24 609 | −346 | 3 459 113 | ||||
| 2024-04-23 | 2024-04-19 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0200 | −18 253 | −256 | 3 483 722 | ||||
| 2024-04-18 | 2024-04-18 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0600 | −2 623 | −37 | 3 501 975 | ||||
| 2024-04-18 | 2024-04-17 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,1500 | −300 | −4 | 3 504 598 | ||||
| 2024-04-18 | 2024-04-16 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,0100 | −14 069 | −197 | 3 504 898 | ||||
| 2024-04-15 | 2024-04-12 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,4200 | −23 101 | −333 | 3 518 967 | ||||
| 2024-04-15 | 2024-04-11 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 14,4900 | −461 899 | −6 693 | 3 542 068 | ||||
| 2024-02-28 | 2024-02-27 | 4 | Morrell Martha | NPCE | Common Stock | D | 12 500 | 90 262 | ||||||
| 2024-02-28 | 2024-02-27 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 12 500 | 152 204 | ||||||
| 2024-02-28 | 2024-02-27 | 4 | Becker Joel | NPCE | Common Stock | D | 52 470 | 52 470 | ||||||
| 2024-02-06 | 2024-02-05 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,1707 | −3 446 | −52 | 77 762 | ||||
| 2024-02-06 | 2024-02-02 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0691 | −14 143 | −213 | 81 208 | ||||
| 2024-02-01 | 2024-02-01 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0393 | −663 | −10 | 95 351 | ||||
| 2024-02-01 | 2024-01-31 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0752 | −1 923 | −29 | 96 014 | ||||
| 2024-02-01 | 2024-01-30 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0954 | −11 262 | −170 | 97 937 | ||||
| 2024-01-26 | 2024-01-25 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0000 | −1 | −0 | 109 199 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Morrell Martha | NPCE | Common Stock | D | 15,0250 | −827 | −12 | 109 200 | ||||
| 2023-12-28 | 2023-12-27 | 4 | Morrell Martha | NPCE | Common Stock | D | 10,1239 | −13 300 | −135 | 110 027 | ||||
| 2023-12-28 | 2023-12-26 | 4 | Morrell Martha | NPCE | Common Stock | D | 10,0000 | −102 | −1 | 123 327 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 10,1448 | −2 730 | −28 | 123 429 | ||||
| 2023-12-07 | 2023-12-06 | 4 | Morrell Martha | NPCE | Common Stock | D | 8,1575 | −11 005 | −90 | 126 159 | ||||
| 2023-12-01 | 2023-12-01 | 4 | KCK LTD. | NPCE | Common Stock | D | 8,7300 | −3 241 | −28 | 5 593 773 | ||||
| 2023-12-01 | 2023-11-30 | 4 | KCK LTD. | NPCE | Common Stock | D | 8,8400 | −7 282 | −64 | 5 597 014 | ||||
| 2023-12-01 | 2023-11-29 | 4 | KCK LTD. | NPCE | Common Stock | D | 8,7200 | −5 644 | −49 | 5 604 296 | ||||
| 2023-11-29 | 2023-11-28 | 4 | KCK LTD. | NPCE | Common Stock | D | 8,7500 | −4 681 | −41 | 5 609 940 | ||||
| 2023-11-29 | 2023-11-27 | 4 | KCK LTD. | NPCE | Common Stock | D | 8,9600 | −6 490 | −58 | 5 614 621 | ||||
| 2023-10-04 | 2023-10-03 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 9,0200 | −700 | −6 | 4 003 967 | ||||
| 2023-10-04 | 2023-10-02 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 9,0800 | −7 614 | −69 | 4 004 667 | ||||
| 2023-02-22 | 2023-02-20 | 4 | Ridley Irina | NPCE | Common Stock | D | 80 000 | 141 139 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 80 000 | 139 704 | ||||||
| 2023-02-22 | 2023-02-21 | 4 | Favet Michael | NPCE | Common Stock | D | 225 000 | 407 080 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Morrell Martha | NPCE | Common Stock | D | 80 000 | 137 164 | ||||||
| 2023-01-09 | 3 | Geiger Uri See Footnote (1) | NPCE | Common Stock | I | 4 432 948 | ||||||||
| 2022-11-23 | 2022-11-22 | 4 | Accelmed Partners II L.P. | NPCE | Common Stock | D | 1,4990 | 62 398 | 94 | 4 432 948 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Accelmed Partners II L.P. | NPCE | Common Stock | D | 1,4990 | 327 893 | 492 | 4 370 550 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 0,0260 | 482 | 0 | 59 704 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 0,0260 | 254 | 0 | 59 222 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 0,0260 | 692 | 0 | 58 968 | ||||
| 2022-10-20 | 2022-10-18 | 4 | LACOB JOSEPH | NPCE | Common Stock | D | 0,0260 | 192 | 0 | 384 | ||||
| 2022-10-11 | 2022-10-07 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 384 | 0 | 57 164 | ||||
| 2022-10-11 | 2022-10-07 | 4 | Morrell Martha | NPCE | Common Stock | D | 0,0260 | 192 | 0 | 56 780 | ||||
| 2022-06-09 | 2022-06-08 | 4 | Ridley Irina | NPCE | Common Stock | D | 5,7780 | −2 500 | −14 | 61 139 | ||||
| 2022-03-08 | 2022-03-08 | 4 | Favet Michael | NPCE | Stock Option (Right to Buy) | D | 8,10 | 310 160 | 310 160 | |||||
| 2022-03-08 | 2022-03-08 | 4 | Favet Michael | NPCE | Common Stock | D | 155 080 | 182 080 | ||||||
| 2022-03-07 | 2022-03-03 | 4 | Kuhn Rebecca | NPCE | Stock Option (Right to Buy) | D | 8,15 | 93 480 | 93 480 | |||||
| 2022-03-07 | 2022-03-03 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 46 740 | 58 276 | ||||||
| 2022-03-07 | 2022-03-03 | 4 | Ridley Irina | NPCE | Stock Option (Right to Buy) | D | 8,15 | 83 530 | 83 530 | |||||
| 2022-03-07 | 2022-03-03 | 4 | Ridley Irina | NPCE | Common Stock | D | 56 987 | 63 639 | ||||||
| 2022-03-07 | 2022-03-03 | 4 | Morrell Martha | NPCE | Stock Option (Right to Buy) | D | 8,15 | 93 530 | 93 530 | |||||
| 2022-03-07 | 2022-03-03 | 4 | Morrell Martha | NPCE | Common Stock | D | 46 760 | 56 588 | ||||||
| 2022-03-01 | 2022-02-28 | 4 | Ridley Irina | NPCE | Common Stock | D | 7,5386 | −1 470 | −11 | 6 652 | ||||
| 2021-11-02 | 2021-11-01 | 4 | Andrade Lisa | NPCE | Stock Option (Right to Buy) | D | 15,63 | 11 836 | 11 836 | |||||
| 2021-10-08 | 2021-04-21 | 4 | Ryan Renee | NPCE | Stock Option (Right to Buy) | D | 17,00 | 21 698 | 21 698 | |||||
| 2021-10-08 | 2021-04-21 | 4 | Norton Evan | NPCE | Stock Option (Right to Buy) | D | 17,00 | 21 698 | 21 698 | |||||
| 2021-10-08 | 2021-04-21 | 4 | Kumar Rakhi | NPCE | Stock Option (Right to Buy) | D | 17,00 | 21 698 | 21 698 | |||||
| 2021-10-08 | 2021-04-21 | 4 | LACOB JOSEPH | NPCE | Stock Option (Right to Buy) | D | 17,00 | 21 698 | 21 698 | |||||
| 2021-06-29 | 2021-06-04 | 4/A | Favet Michael | NPCE | Stock Option (Right to Buy) | D | 21,67 | 54 000 | 54 000 | |||||
| 2021-06-29 | 2021-06-04 | 4/A | Favet Michael | NPCE | Common Stock | D | 27 000 | 27 000 | ||||||
| 2021-06-29 | 2021-06-04 | 4/A | Morrell Martha | NPCE | Stock Option (Right to Buy) | D | 21,67 | 16 620 | 16 620 | |||||
| 2021-06-29 | 2021-06-04 | 4/A | Morrell Martha | NPCE | Common Stock | D | 8 310 | 9 828 | ||||||
| 2021-06-29 | 2021-06-04 | 4/A | Kuhn Rebecca | NPCE | Stock Option (Right to Buy) | D | 21,67 | 16 620 | 16 620 | |||||
| 2021-06-29 | 2021-06-04 | 4/A | Kuhn Rebecca | NPCE | Common Stock | D | 8 310 | 11 536 | ||||||
| 2021-06-29 | 2021-06-04 | 4/A | Ridley Irina | NPCE | Stock Option (Right to Buy) | D | 21,67 | 11 540 | 11 540 | |||||
| 2021-06-29 | 2021-06-04 | 4/A | Ridley Irina | NPCE | Common Stock | D | 5 770 | 8 122 | ||||||
| 2021-06-08 | 2021-06-04 | 4 | Morrell Martha | NPCE | Stock Option (Right to Buy) | D | 21,67 | 16 363 | 16 363 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Morrell Martha | NPCE | Common Stock | D | 8 181 | 9 699 | ||||||
| 2021-06-08 | 2021-06-04 | 4 | Favet Michael | NPCE | Stock Option (Right to Buy) | D | 21,67 | 53 180 | 53 180 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Favet Michael | NPCE | Common Stock | D | 26 590 | 26 590 | ||||||
| 2021-06-08 | 2021-06-04 | 4 | Ridley Irina | NPCE | Stock Option (Right to Buy) | D | 21,67 | 11 363 | 11 363 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Ridley Irina | NPCE | Common Stock | D | 5 681 | 8 033 | ||||||
| 2021-06-08 | 2021-06-04 | 4 | Kuhn Rebecca | NPCE | Stock Option (Right to Buy) | D | 21,67 | 16 363 | 16 363 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Kuhn Rebecca | NPCE | Common Stock | D | 8 181 | 11 407 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Series B' Preferred Stock | I | 0,00 | −3 605 386 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Series A' Preferred Stock | I | 0,00 | −171 895 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | ORBIMED ADVISORS LLC See Footnotes | NPCE | Common Stock | I | 3 777 281 | 4 012 281 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | Fischer Frank M | NPCE | Series B' Preferred Stock | D | 0,00 | −450 880 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Fischer Frank M | NPCE | Series A' Preferred Stock | D | 0,00 | −21 486 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Fischer Frank M | NPCE | Common Stock | D | 472 366 | 565 657 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | Accelmed Partners II L.P. | NPCE | Series B' Preferred Stock | D | 0,00 | 3 454 422 | 3 454 422 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Accelmed Partners II L.P. | NPCE | Common Stock | D | 3 454 422 | 4 042 657 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | Norton Evan | NPCE | Series B' Preferred Stock | I | 0,00 | −3 454 422 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Norton Evan | NPCE | Common Stock | I | 3 454 422 | 4 042 657 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | Garfield Greg Shaw | NPCE | Series B' Preferred Stock | I | 0,00 | −5 271 902 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Garfield Greg Shaw | NPCE | Series A' Preferred Stock | I | 0,00 | −323 591 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Garfield Greg Shaw | NPCE | Series B' Preferred Stock | I | 0,00 | −18 032 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Garfield Greg Shaw | NPCE | Series A' Preferred Stock | I | 0,00 | −859 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Garfield Greg Shaw | NPCE | Common Stock | I | 5 595 493 | 5 614 384 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | Garfield Greg Shaw | NPCE | Common Stock | I | 18 891 | 18 891 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | LACOB JOSEPH | NPCE | Series B' Preferred Stock | I | 0,00 | −205 497 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | LACOB JOSEPH | NPCE | Series B; Preferred Stock | I | 0,00 | −102 747 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | LACOB JOSEPH | NPCE | Series A' Preferred Stock | I | 0,00 | −17 189 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | LACOB JOSEPH | NPCE | Series A' Preferred Stock | I | 0,00 | −8 594 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | LACOB JOSEPH | NPCE | Common Stock | I | 334 027 | 351 920 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | Favet Michael | NPCE | Series B' Preferred Stock | I | 0,00 | −7 219 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Favet Michael | NPCE | Series A' Preferred Stock | I | 0,00 | −343 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | Favet Michael | NPCE | Common Stock | I | 0,0300 | 15 385 | 0 | 22 947 | ||||
| 2021-04-26 | 2021-04-26 | 4 | Favet Michael | NPCE | Common Stock | I | 7 562 | 7 562 | ||||||
| 2021-04-26 | 2021-04-26 | 4 | KCK LTD. | NPCE | Series B' Prime Preferred Stock | D | 0,00 | −5 271 902 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | KCK LTD. | NPCE | Series A' Prime Preferred Stock | D | 0,00 | −323 591 | 0 | |||||
| 2021-04-26 | 2021-04-26 | 4 | KCK LTD. | NPCE | Common Stock | D | 5 595 493 | 5 621 111 | ||||||
| 2021-04-23 | 2021-04-21 | 4 | ORBIMED ADVISORS LLC | NPCE | Common Stock | I | 17,0000 | 235 000 | 3 995 | 235 000 | ||||
| 2021-04-23 | 2021-04-21 | 4 | Ridley Irina | NPCE | Common Stock | D | 17,0000 | 2 352 | 40 | 2 352 | ||||
| 2021-04-23 | 2021-04-21 | 4 | Accelmed Partners II L.P. | NPCE | Common Stock | D | 17,0000 | 588 235 | 10 000 | 588 235 | ||||
| 2021-04-23 | 2021-04-21 | 4 | Fischer Frank M | NPCE | Stock Option (Right to Buy) | D | 17,00 | 21 698 | 21 698 | |||||
| 2021-04-23 | 2021-04-21 | 4 | Fischer Frank M | NPCE | Common Stock | D | 17,0000 | 50 000 | 850 | 93 291 | ||||
| 2021-04-23 | 2021-04-21 | 4 | Garfield Greg Shaw | NPCE | Stock Option (Right to Buy) | D | 17,00 | 21 698 | 21 698 | |||||
| 2021-04-23 | 2021-04-21 | 4 | Garfield Greg Shaw | NPCE | Common Stock | D | 17,0000 | 13 235 | 225 | 38 853 | ||||
| 2021-04-23 | 2021-04-21 | 4 | Norton Evan | NPCE | Common Stock | I | 17,0000 | 588 235 | 10 000 | 588 235 | ||||
| 2021-04-20 | 3 | Morrell Martha | NPCE | Common Stock | D | 1 518 | ||||||||
| 2021-04-20 | 3 | KCK LTD. | NPCE | Common Stock | D | 25 618 | ||||||||
| 2021-04-20 | 3 | Fischer Frank M | NPCE | Common Stock | D | 43 291 | ||||||||
| 2021-04-20 | 3 | LACOB JOSEPH | NPCE | Common Stock | I | 868 | ||||||||
| 2021-04-20 | 3 | LACOB JOSEPH | NPCE | Common Stock | I | 16 833 | ||||||||
| 2021-04-20 | 3 | LACOB JOSEPH | NPCE | Common Stock | D | 192 | ||||||||
| 2021-04-20 | 3 | Kuhn Rebecca | NPCE | Common Stock | D | 3 226 | ||||||||
| 2021-04-20 | 3 | Ryan Renee | NPCE | Common Stock | D | 41 170 | ||||||||
| 2021-04-20 | 3 | Favet Michael | NPCE | Common Stock | I | 15 385 | ||||||||
| 2021-04-20 | 3 | Garfield Greg Shaw | NPCE | Common Stock | I | 25 618 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
